Yıl: 2021 Cilt: 38 Sayı: 3 Sayfa Aralığı: 166 - 172 Metin Dili: İngilizce DOI: 10.4103/nsn.nsn_57_21 İndeks Tarihi: 11-06-2022

Antiviral MicroRNA Expression Signatures are Altered in Subacute Sclerosing Panencephalitis

Öz:
Background: Subacute sclerosing panencephalitis (SSPE) is a chronic, progressive disease caused by a persistent infection of the measles virus. Despite extensive efforts, the exact neurodegeneration mechanism in SSPE remains unknown. MicroRNAs (miRNAs) have emerged as an essential part of cellular antiviral defense mechanisms and can be modulated by antiviral cytokines Such as interferon‐beta (IFN‐β). Aims and Objectives: In this study, we aimed to elucidate the role of antiviral miRNAs in the pathogenesis of SSPE and analyze the interaction between host antiviral miRNAs and virus genes. Materials and Methods: Thirty‐seven patients who were followed with SSPE and age‐matched healthy children were included in the study. Peripheral blood mononuclear cell levels of miR‐196b, miR‐296, miR‐431, and miR‐448 were analyzed using quantitative polymerase chain reaction. Target predictions and pathway constructions of deregulated miRNAs were assessed. Results: Here, we showed that IFN‐β‐ modulated miR‐196b, miR‐296, and miR‐431 were significantly upregulated in patients with SSPE compared with healthy controls. Besides, sequence complementarity analysis showed that miR‐296 and miR‐196b predicted binding regions in measles virus genomic RNA. Conclusion: Our findings suggest that antiviral miRNAs are upregulated in patients with SSPE, which could be a part of the host antiviral defense mechanism.
Anahtar Kelime:

Belge Türü: Makale Makale Türü: Araştırma Makalesi Erişim Türü: Erişime Açık
  • 1. Mekki M, Eley B, Hardie D, Wilmshurst JM. Subacute sclerosing panencephalitis: Clinical phenotype, epidemiology, and preventive interventions. Dev Med Child Neurol 2019;61:1139‑44.
  • 2. Solomon T, Hart CA, Vinjamuri S, Beeching NJ, Malucc Humphrey P. Treatment of subacute sclerosing panencephalitis with interferon‑alpha, ribavirin, and inosiplex. J Child Neurol 2002;17:703‑5.
  • 3. Anlar B, Yalaz K, Imir T, Turanli G. The effect of inosiplex in subacute sclerosing panencephalitis: A clinical and laboratory study. Eur Neurol 1994;34:44‑7.
  • 4. Pedersen IM, Cheng G, Wieland S, Volinia S, Croce CM, Chisari FV, et al. Interferon modulation of cellular microRNAs as an antiviral mechanism. Nature 2007;449:919‑22.
  • 5. Nagano I, Nakamura S, Yoshioka M, Onodera J, Kogure K, Itoyama Y. Expression of cytokines in brain lesions in subacute sclerosing panencephalitis. Neurology 1994;44:710‑5.
  • 6. O’Connell RM, Rao DS, Baltimore D. microRNA regulation of inflammatory responses. Ann Rev Immunol 2012;30:295‑312.
  • 7. Yiş U, Tüfekçi UK, Genç Ş, Çarman KB, Bayram E, Topçu Y, et al. Expression patterns of micro‑RNAs 146a, 181a, and 155 in subacute sclerosing panencephalitis. J Child Neurol 2015;30:69‑74.
  • 8. Cakmak Genc G, Dursun A, Karakas Celik S, Calik M, Kokturk F, Piskin IE. IL28B, IL29 and micro‑RNA 548 in subacute sclerosing panencephalitis as a rare disease. Gene 2018;678:73‑8.
  • 9. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real‑time quantitative PCR and the 2(‑Delta Delta C (T)) Method. Methods 2001;25:402‑8.
  • 10. Kanehisa M, Goto S, Sato Y, Kawashima M, Furumichi M, Tanabe M. Data, information, knowledge and principle: Back to metabolism in KEGG. Nucleic Acids Res 2014;42:D199‑205.
  • 11. Saito R, Smoot ME, Ono K, Ruscheinski J, Wang PL, Lotia S, et al. A travel guide to Cytoscape plugins. Nat Methods 2012;9:1069‑76.
  • 12. Cline MS, Smoot M, Cerami E, Kuchinsky A, Landys N, Workman C,et al. Integration of biological networks and gene expression data using Cytoscape. Nat Protoc 2007;2:2366‑82.
  • 13. Shannon P, Markiel A, Ozier O, Baliga NS, Wang JT, Ramage D, et al. Cytoscape: A software environment for integrated models of biomolecular interaction networks. Genome Res 2003;13:2498‑504.
  • 14. Kozomara A, Griffiths‑Jones S. miRBase: Annotating high confidence microRNAs using deep sequencing data. Nucleic Acids Res 2014;42:D68‑73.
  • 15. Hsu SD, Tseng YT, Shrestha S, Lin YL, Khaleel A, Chou C et al. miRTarBase update 2014: An information resource for experimentally validated miRNA‑target interactions. Nucleic Acids Res 2014;42:D78‑85.
  • 16. Sethupathy P, Corda B, Hatzigeorgiou AG. TarBase: A comprehensive database of experimentally supported animal microRNA targets. RNA 2006;12:192‑7.
  • 17. Vergoulis T, Vlachos IS, Alexiou P, Georgakilas G, Maragkakis M, Reczko M, et al. TarBase 6.0: Capturing the exponential growth of miRNA targets with experimental support. Nucleic Acids Res 2012;40:D222‑9.
  • 18. Altschul SF, Gish W, Miller W, Myers EW, Lipman DJ. Basic local alignment search tool. J Mol Biol 1990;215:403‑10.
  • 19. Lecellier CH, Dunoyer P, Arar K, Lehmann‑Che J, Eyquem S, Himber C, et al. A cellular microRNA mediates antiviral defense in human cells. Science 2005;308:557‑60.
  • 20. Hou ZH, Han QJ, Zhang C, Tian ZG, Zhang J. miR146a impairs the IFN‑induced anti‑HBV immune response by downregulating STAT1 in hepatocytes. Liver Int 2014;34:58‑68.
  • 21. Collins SE, Noyce RS, Mossman KL. Innate cellular response to virus particle entry requires IRF3 but not virus replication. J Virol 2004;78:1706‑17.
  • 22. tenOever BR, Servant MJ, Grandvaux N, Lin R, Hiscott J. Recognition of the measles virus nucleocapsid as a mechanism of IRF‑3 activation. J Virol 2002;76:3659‑69
APA TÜFEKÇİ K, ALLMER J, ÇARMAN K, Bayram E, TOPÇU Y, HIZ S, GENÇ Ş, YİŞ U (2021). Antiviral MicroRNA Expression Signatures are Altered in Subacute Sclerosing Panencephalitis. , 166 - 172. 10.4103/nsn.nsn_57_21
Chicago TÜFEKÇİ Kemal Uğur,ALLMER Jens,ÇARMAN Kürşat Bora,Bayram Erhan,TOPÇU Yasemin,HIZ Semra,GENÇ Şermin,YİŞ Uluç Antiviral MicroRNA Expression Signatures are Altered in Subacute Sclerosing Panencephalitis. (2021): 166 - 172. 10.4103/nsn.nsn_57_21
MLA TÜFEKÇİ Kemal Uğur,ALLMER Jens,ÇARMAN Kürşat Bora,Bayram Erhan,TOPÇU Yasemin,HIZ Semra,GENÇ Şermin,YİŞ Uluç Antiviral MicroRNA Expression Signatures are Altered in Subacute Sclerosing Panencephalitis. , 2021, ss.166 - 172. 10.4103/nsn.nsn_57_21
AMA TÜFEKÇİ K,ALLMER J,ÇARMAN K,Bayram E,TOPÇU Y,HIZ S,GENÇ Ş,YİŞ U Antiviral MicroRNA Expression Signatures are Altered in Subacute Sclerosing Panencephalitis. . 2021; 166 - 172. 10.4103/nsn.nsn_57_21
Vancouver TÜFEKÇİ K,ALLMER J,ÇARMAN K,Bayram E,TOPÇU Y,HIZ S,GENÇ Ş,YİŞ U Antiviral MicroRNA Expression Signatures are Altered in Subacute Sclerosing Panencephalitis. . 2021; 166 - 172. 10.4103/nsn.nsn_57_21
IEEE TÜFEKÇİ K,ALLMER J,ÇARMAN K,Bayram E,TOPÇU Y,HIZ S,GENÇ Ş,YİŞ U "Antiviral MicroRNA Expression Signatures are Altered in Subacute Sclerosing Panencephalitis." , ss.166 - 172, 2021. 10.4103/nsn.nsn_57_21
ISNAD TÜFEKÇİ, Kemal Uğur vd. "Antiviral MicroRNA Expression Signatures are Altered in Subacute Sclerosing Panencephalitis". (2021), 166-172. https://doi.org/10.4103/nsn.nsn_57_21
APA TÜFEKÇİ K, ALLMER J, ÇARMAN K, Bayram E, TOPÇU Y, HIZ S, GENÇ Ş, YİŞ U (2021). Antiviral MicroRNA Expression Signatures are Altered in Subacute Sclerosing Panencephalitis. Neurological sciences and neurophysiology (Online), 38(3), 166 - 172. 10.4103/nsn.nsn_57_21
Chicago TÜFEKÇİ Kemal Uğur,ALLMER Jens,ÇARMAN Kürşat Bora,Bayram Erhan,TOPÇU Yasemin,HIZ Semra,GENÇ Şermin,YİŞ Uluç Antiviral MicroRNA Expression Signatures are Altered in Subacute Sclerosing Panencephalitis. Neurological sciences and neurophysiology (Online) 38, no.3 (2021): 166 - 172. 10.4103/nsn.nsn_57_21
MLA TÜFEKÇİ Kemal Uğur,ALLMER Jens,ÇARMAN Kürşat Bora,Bayram Erhan,TOPÇU Yasemin,HIZ Semra,GENÇ Şermin,YİŞ Uluç Antiviral MicroRNA Expression Signatures are Altered in Subacute Sclerosing Panencephalitis. Neurological sciences and neurophysiology (Online), vol.38, no.3, 2021, ss.166 - 172. 10.4103/nsn.nsn_57_21
AMA TÜFEKÇİ K,ALLMER J,ÇARMAN K,Bayram E,TOPÇU Y,HIZ S,GENÇ Ş,YİŞ U Antiviral MicroRNA Expression Signatures are Altered in Subacute Sclerosing Panencephalitis. Neurological sciences and neurophysiology (Online). 2021; 38(3): 166 - 172. 10.4103/nsn.nsn_57_21
Vancouver TÜFEKÇİ K,ALLMER J,ÇARMAN K,Bayram E,TOPÇU Y,HIZ S,GENÇ Ş,YİŞ U Antiviral MicroRNA Expression Signatures are Altered in Subacute Sclerosing Panencephalitis. Neurological sciences and neurophysiology (Online). 2021; 38(3): 166 - 172. 10.4103/nsn.nsn_57_21
IEEE TÜFEKÇİ K,ALLMER J,ÇARMAN K,Bayram E,TOPÇU Y,HIZ S,GENÇ Ş,YİŞ U "Antiviral MicroRNA Expression Signatures are Altered in Subacute Sclerosing Panencephalitis." Neurological sciences and neurophysiology (Online), 38, ss.166 - 172, 2021. 10.4103/nsn.nsn_57_21
ISNAD TÜFEKÇİ, Kemal Uğur vd. "Antiviral MicroRNA Expression Signatures are Altered in Subacute Sclerosing Panencephalitis". Neurological sciences and neurophysiology (Online) 38/3 (2021), 166-172. https://doi.org/10.4103/nsn.nsn_57_21